Global Thrombin Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Thrombin Market Research Report 2024
Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
According to Mr Accuracy reports new survey, global Thrombin market is projected to reach US$ 704.7 million in 2029, increasing from US$ 565 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thrombin market research.
Key manufacturers engaged in the Thrombin industry include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Thrombin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Thrombin market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thrombin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Segment by Type
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Hospitals
Diagnostics & Clinics
Academic and Research Institute
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Thrombin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Thrombin market is projected to reach US$ 704.7 million in 2029, increasing from US$ 565 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thrombin market research.
Key manufacturers engaged in the Thrombin industry include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Thrombin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Thrombin market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thrombin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Segment by Type
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Segment by Application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Thrombin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source